Tag: Atrial Fibrillation
Rates of Adverse Events Lower With Apixaban for A-Fib in Older Adults
Apixaban the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels
Athletes Have Higher Risk for Developing Atrial Fibrillation
Risk greater in athletes younger than 55 years and among those participating in mixed sport versus endurance sport
Preablation Weight Loss Linked to Freedom From A-Fib
Change in weight over preceding year linked to success of catheter ablation for AF at 15 months for obese, nonobese patients
Catheter Ablation Improves A-Fib Outcomes in Racial/Ethnic Minorities
In contrast, much higher event rate seen for racial and ethnic minorities randomly assigned to drug therapy in CABANA trial
Accelerometer-Derived Physical Activity Tied to Drop in Risk for A-Fib
Significant reductions seen in risks for atrial fibrillation, stroke with guideline-adherent physical activity assessed with accelerometer
Cardiac Monitor Implant Detects A-Fib in More Stroke Patients
Rate of incident AF over 12 months higher with implant versus usual care with external cardiac monitoring in patients with ischemic stroke
Fish Oil Supplements Tied to Risk for Atrial Fibrillation
Patients at high risk for cardiovascular disease or who had established cardiovascular disease had higher risk for a-fib with fish oil supplements
ACC: Occlusion of Left Atrial Appendage Prevents Stroke in A-Fib
Risk for stroke or systemic embolism reduced with versus without concomitant occlusion during an otherwise indicated cardiac surgery
Undiagnosed A-Fib Detected During Diabetic Foot Exam
One in six patients with diabetes had previously undiagnosed atrial fibrillation with similar rates in men and women
Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
Among patients with a-fib and/or VTE, about one-third received ASA in addition to a DOAC with no clear indication for ASA
